Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...
Measles cases are popping up across the country, especially in areas with lower vaccination rates. Video above: NH trails ...
One concern with bispecific antibody therapies in community settings is managing adverse events, with emerging patterns ...
Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...
Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...
Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...
Pemphigus is a rare autoimmune disease that causes painful blisters on the skin and mucous membranes, including the mouth, ...
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback